Dr. Brian K. Chang, MD

Dr. Chang practices at Ft Wayne Cardiac Center LLC in Fort Wayne, Indiana.

Dr. Chang's NPI, 1245364926, was assigned on March 15, 2007. Dr. Chang graduated from Tufts University School Of Medicine in 2002. Dr. Chang's Indiana license number on file is 01063272A.

Dr. Chang's primary practice is Ft Wayne Cardiac Center LLC, at 7910 W Jefferson Blvd, Fort Wayne, IN 46804 in Allen County. The practice phone is (260) 432-2297.

Dr. Chang's primary practice is Ft Wayne Cardiac Center LLC in Fort Wayne, Indiana. Dr. Chang is also affiliated with Parkview Regional Medical Center. The medical group on file is Radiation Oncology Associates. Dmand AI also links Dr. Chang to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chang practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Chang's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Chang is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Chang's licenses on file in 4 states: Indiana, Ohio, Iowa and Pennsylvania.

Dmand AI lists anal cancer radiation, bone cancer radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, head & neck cancer radiation, lung cancer radiation and lymphoma radiation among the conditions Dr. Chang treats.

CMS data shows 2,872 Medicare services from Dr. Chang across 16 procedure codes in 2024, for 293 Medicare patients. Medicare paid $203,847 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 293 Medicare patients who saw Dr. Chang in 2024. The largest group is 65 to 74, with 167 patients. 75% of them have cancer, and 75% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chang's median patient age at 70, with 39% women.

In 2024, Dr. Chang wrote 248 Medicare Part D claims for 121 patients. 85% of them were for generic drugs. CMS names the drug for 179 of them, across 4 drugs with 11 or more claims each, at $85,097 in total drug cost. In 2023, CMS named 123 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Chang for performance year 2024, reported individually. Dr. Chang accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Chang, published from 2016 to 2024. Dr. Chang's most frequent co-authors are Douglas Middleton Dahl, MD, Marc Dror Michaelson, MD, PhD and Huong T. Pham, MD.

Dmand AI links Dr. Chang to 31 clinical trials, 18 of them phase 3 studies. 16 are still active or recruiting. Conditions studied include Prostatic Neoplasms, Prostatic Diseases and Glioblastoma. Radiation Therapy Oncology Group sponsors the most, 11.

CMS Open Payments shows 63 general payments to Dr. Chang from 19 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 46% of the total. Myovant Sciences Inc. paid the most, $8,956.

Dr. Chang graduated from Tufts University School Of Medicine in 2002. Dr. Chang is a member of ASCO.

Dr. Chang is in network with 16 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.